Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Yamaguchi University
Yamaguchi University_20100114

Yamaguchi University patents


Recent patent applications related to Yamaguchi University. Yamaguchi University is listed as an Agent/Assignee. Note: Yamaguchi University may have other listings under different names/spellings. We're not affiliated with Yamaguchi University, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "Y" | Yamaguchi University-related inventors


Therapeutic agent for keratoconjunctive disorders

The present invention addresses the problem of providing a novel therapeutic agent for keratoconjunctive disorders. As a means for solving the problem, a therapeutic agent for keratoconjunctive disorders which contains a RARγ agonist as an active ingredient is provided. The therapeutic agent exhibits an excellent ameliorating effect in a keratoconjunctive... Yamaguchi University

Thickening and stabilizing agent, and thickening and stabilizing composition using same

where R1 is a group resulting from removing four hydrogen atoms from the structural formula of butane; R2 and R3 are different from each other and are aliphatic hydrocarbon groups each containing 4 or more carbon atoms; and n is an integer of 1 to 3.... Yamaguchi University

Car expression vector and car-expressing t cells

A CAR expression vector comprises a nucleic acid encoding a chimeric antigen receptor (CAR) and a nucleic acid encoding a T cell immune function-enhancing factor, wherein the nucleic acid encoding an immune function-enhancing factor is a nucleic acid encoding interleukin-7 and a nucleic acid encoding CCL19, a nucleic acid encoding... Yamaguchi University

Method for detecting bcr-abl inhibitor resistance-related mutation and data acquisition predicting bcr-abl inhibitor resistance using the same

An object of the present invention is to detect a mutation related to BCR-ABL inhibitor resistance with high accuracy for chronic myelogenous leukemia or the like. A method for detecting the mutation comprises the steps of: amplifying a region including a fusion site and a mutation site related to BCR-ABL... Yamaguchi University

Method for evaluating mesenchymal stem cell activity, culturing mesenchymal stem cells, producing therapeutic agent for liver dysfunction, and therapeutic agent for liver dysfunction

In this method, the activity level of mesenchymal stem cells can be evaluated from the assayed amount of AK4, for instance, if the mitochondrial activity level of mesenchymal stem cells is high, the mesenchymal stem cells can be evaluated as ideal for use as a therapeutic agent, while if mitochondrial... Yamaguchi University

Thickening stabilizer and thickening stabilization composition using same

The compound of the present invention is represented by the following formula (1). In the formula, R1 and R2 are different from each other and represent an aliphatic hydrocarbon group having not less than 4 carbon atoms, and n represents an integer of 1 to 3. The thickening/stabilizing agent of... Yamaguchi University

Thickening/stabilizing agent and thickened/stabilized composition using the same

where R1 is a group resulting from removing four hydrogen atoms from the structural formula of an aromatic hydrocarbon or cyclohexane; R2 is, independently in each occurrence, an aliphatic hydrocarbon group containing 1 to 4 carbon atoms; R3 is, independently in each occurrence, an aliphatic hydrocarbon group containing 6 or... Yamaguchi University

Stent made of polymer material having ratchet

A plurality of branch bars is provided on opposing sides of paired strut pieces connected by links in a strut to protrude from one towards the other side, and a plurality of ratchet teeth is formed on the side of the branch bars respectively. When a stent made of polymer... Yamaguchi University

Therapeutic agent for keratoconjunctive disorders

The present invention addresses the problem of providing a novel therapeutic agent for keratoconjunctive disorders. As a means for solving the problem, a therapeutic agent for keratoconjunctive disorders which contains a RARγ agonist as an active ingredient is provided. The therapeutic agent exhibits an excellent ameliorating effect in a keratoconjunctive... Yamaguchi University

Yeast having xylose assimilation ability and ethanol production ability

An object is to provide a thermotolerant yeast capable of assimilating xylose to produce ethanol or a mutant strain thereof and a method for producing ethanol by assimilation of xylose. There is used a yeast, Kluyveromyces marxianus strain No. 21 (accession number: NITE BP-01739), or a mutant strain thereof that... Yamaguchi University








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Yamaguchi University in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Yamaguchi University with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###